References
- Borak J, Diller WF. (2001). Phosgene exposure: mechanisms of injury and treatment strategies. J Occupat Environ Med/Am Coll Occupat Environ Med 43:110–9.
- Colunga AG, Laing JM, Aurelian L. (2010). The HSV-2 mutant DeltaPK induces melanoma oncolysis through nonredundant death programs and associated with autophagy and pyroptosis proteins. Gene Ther 17:315–27.
- Dejana E, Giampietro C. (2012). Vascular endothelial-cadherin and vascular stability. Curr Opin Hematol 19:218–23.
- Dinarello CA. (2004). Unraveling the NALP-3/IL-1beta inflammasome: a big lesson from a small mutation. Immunity 20:243–4.
- Dolinay T, Kim YS, Howrylak J, et al. (2012). Inflammasome-regulated cytokines are critical mediators of acute lung injury. Am J Respir Crit Care Med 185:1225–34.
- Dorfleutner A, Chu L, Stehlik C. (2015). Inhibiting the inflammasome: one domain at a time. Immunol Rev 265:205–16.
- dos Santos G, Kutuzov MA, Ridge KM. (2012). The inflammasome in lung diseases. Am J Physiol Lung Cell Mol Physiol 303:L627–33.
- Eklund L, Kangas J, Saharinen P. (2017). Angiopoietin-Tie signalling in the cardiovascular and lymphatic systems. Clin Sci 131:87–103.
- Fukuhara S, Sako K, Noda K, et al. (2010). Angiopoietin-1/Tie2 receptor signaling in vascular quiescence and angiogenesis. Histol Histopathol 25:387–96.
- Fukumoto J, Fukumoto I, Parthasarathy PT, et al. (2013). NLRP3 deletion protects from hyperoxia-induced acute lung injury. Am J Physiol Cell Physiol 305:C182–9.
- Galam L, Rajan A, Failla A, et al. (2016). Deletion of P2X7 attenuates hyperoxia-induced acute lung injury via inflammasome suppression. Am J Physiol Lung Cell Mol Physiol 310:L572–81.
- Gao H, Neff T, Ward PA. (2006). Regulation of lung inflammation in the model of IgG immune-complex injury. Ann Rev Pathol 1:215–42.
- Grailer JJ, Canning BA, Kalbitz M, et al. (2014). Critical role for the NLRP3 inflammasome during acute lung injury. J Immunol 192:5974–83.
- He DK, Shao YR, Zhang L, et al. (2014). Adenovirus-delivered angiopoietin-1 suppresses NF-κB and p38 MAPK and attenuates inflammatory responses in phosgene-induced acute lung injury. Inhal Toxicol 26:185–92.
- Hu C, Ding H, Li Y, et al. (2015). NLRP3 deficiency protects from type 1 diabetes through the regulation of chemotaxis into the pancreatic islets. Proc Natl Acad Sci USA 112:11318–23.
- Jordan JA, Guo RF, Yun EC, et al. (2001). Role of IL-18 in acute lung inflammation. J Immunol 167:7060–8.
- Kehoe K, Gielis JF, Vliegen G, et al. (2016). Dysregulation of the renin-angiotensin system during lung ischemia-reperfusion injury. Exp Lung Res 42:277–85.
- Kinoshita T, Wang Y, Hasegawa M, et al. (2005). PYPAF3, a PYRIN-containing APAF-1-like protein, is a feedback regulator of caspase-1-dependent interleukin-1beta secretion. J Biol Chem 280:21720–5.
- Koh GY. (2013). Orchestral actions of angiopoietin-1 in vascular regeneration. Trend Mol Med 19:31–9.
- Kolliputi N, Galam L, Parthasarathy PT, et al. (2012). NALP-3 inflammasome silencing attenuates ceramide-induced transepithelial permeability. J Cell Physiol 227:3310–6.
- Kuipers MT, Aslami H, Janczy JR, et al. (2012). Ventilator-induced lung injury is mediated by the NLRP3 inflammasome. Anesthesiology 116:1104–15.
- Li W, Pauluhn J. (2017). Phosgene-induced acute lung injury (ALI): differences from chlorine-induced ALI and attempts to translate toxicology to clinical medicine. Clin Translat Med 6:19.
- Liao J, Kapadia VS, Brown LS, et al. (2015). The NLRP3 inflammasome is critically involved in the development of bronchopulmonary dysplasia. Nat Commun 6:8977.
- Lu A, Wu H. (2015). Structural mechanisms of inflammasome assembly. FEBS J 282:435–44.
- Luo YP, Jiang L, Kang K, et al. (2014). Hemin inhibits NLRP3 inflammasome activation in sepsis-induced acute lung injury, involving heme oxygenase-1. Int Immunopharmacol 20:24–32.
- Makabe H, Kojika M, Takahashi G, et al. (2012). Interleukin-18 levels reflect the long-term prognosis of acute lung injury and acute respiratory distress syndrome. J Anesth 26:658–63.
- Manji GA, Wang L, Geddes BJ, et al. (2002). PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-kappa B. J Biol Chem 277:11570–5.
- McCarter SD, Mei SH, Lai PF, et al. (2007). Cell-based angiopoietin-1 gene therapy for acute lung injury. Am J Respirat Crit Care Med 175:1014–26.
- Pauluhn J, Carson A, Costa DL, et al. (2007). Workshop summary: phosgene-induced pulmonary toxicity revisited: appraisal of early and late markers of pulmonary injury from animal models with emphasis on human significance [Comparative Study Congresses Research Support, Non-U.S. Gov’t]. Inhal Toxicol 19:789–810.
- Proell M, Gerlic M, Mace PD, et al. (2013). The CARD plays a critical role in ASC foci formation and inflammasome signalling. Biochem J 449:613–21.
- Shah AV, Birdsey GM, Peghaire C, et al. (2017). The endothelial transcription factor ERG mediates angiopoietin-1-dependent control of Notch signalling and vascular stability. Nat Commun 8:16002.
- Shen J, Wang J, Shao YR, et al. (2013). Adenovirus-delivered angiopoietin-1 treatment for phosgene-induced acute lung injury. Inhal Toxicol 25:272–9.
- Shi X, Xie WL, Kong WW, et al. (2015). Expression of the NLRP3 inflammasome in carotid atherosclerosis. J Stroke Cerebrovasc Dis 24:2455–66.
- Tang XD, Shi L, Monsel A, et al. (2017). Mesenchymal stem cell microvesicles attenuate acute lung injury in mice partly mediated by Ang-1 mRNA. Stem Cells 35:1849–59.
- Wu J, Yan Z, Schwartz DE, et al. (2013). Activation of NLRP3 inflammasome in alveolar macrophages contributes to mechanical stretch-induced lung inflammation and injury. J Immunol 190:3590–9.
- Yang P, Chen N, Jia JH, et al. (2015). Tie-1: A potential target for anti-angiogenesis therapy. J Huazhong Univ Sci Technol Med Sci 35:615–22.
- Yin N, Peng Z, Li B, et al. (2016). Isoflurane attenuates lipopolysaccharide-induced acute lung injury by inhibiting ROS-mediated NLRP3 inflammasome activation. Am J Translat Res 8:2033–46.
- Zhang J, Fukuhara S, Sako K, et al. (2011). Angiopoietin-1/Tie2 signal augments basal Notch signal controlling vascular quiescence by inducing delta-like 4 expression through AKT-mediated activation of beta-catenin. J Biol Chem 286:8055–66.
- Zhang J, Zhang K, Li Z, Guo B. (2016). ER stress-induced inflammasome activation contributes to hepatic inflammation and steatosis. J Clin Cell Immunol 7:457.
- Zhang Q, Wu D, Yang Y, et al. (2017). Dexmedetomidine alleviates hyperoxia-induced acute lung injury via inhibiting NLRP3 inflammasome activation. Cell Physiol Biochem 42:1907–19.